The first steps have begun to find Petplan and The Veterinary Business Journal's Practice Manager of the Year for 2012.
Nominations are now being sought for the most accomplished UK practice managers and recommendations are welcome from any member of the veterinary team.
Three finalists will be chosen and the winner announced at the annual Petplan Veterinary Awards in April 2012.
Robin Fearon, editor of the Veterinary Business Journal, said: "It is a distinct pleasure to launch the awards programme each year knowing that at the end of it we will be able to announce another winning practice manager.
"These awards are so important in promoting the role and highlighting the crucial part that managers play in practice strategy and success - we can't wait to see your nominations."
Judges will assess candidates' applications and choose the three finalists based on their competency in areas such as staff development, financial strategy and marketing initiative.
Last year's winner Denise Coston is practice manager at Castle Veterinary Surgeons in County Durham. She said: "Winning this award has meant a lot to me because it makes you feel valued. I would say to anyone thinking of nominating their practice manager: 'just do it'.
"The role of practice manager varies in each practice and can be hard to quantify with specific measures, but it means a lot to celebrate someone getting it right. It is an excellent way to promote the role of practice manager and it is great to get recognition alongside vets and nurses."
This award is supported by the Society of Practising Veterinary Surgeons and the Veterinary Practice Management Association.
As well as a plaque commemorating their achievements, the winner will once more receive one year's free membership to the VPMA.
Nominations for this year's award close on 10 February 2012. Application packs are available from: Jackie Morrison, The Veterinary Business Journal, Olympus House, Werrington Centre, Peterborough PE4 6NA, or e-mail jackiemorrison@vbd.uk.com.
Alternatively visit www.vetsonline.com/ to download yours direct.
Ceredigion veterinary surgeon Robert Alun Merfyn Evans has been suspended from the Register for six months by the RCVS Disciplinary Committee after he admitted to misconduct relating to tuberculin testing for cattle he owned and failing to register the births and deaths of cattle.
Mr Evans appeared before the Committee on the 11th February, when he admitted the two heads of charge of misconduct against him.
The first head of charge related to the fact that, between 24 June and 29 June 2013, he deliberately failed to bring to attention of Wyn Lewis MRCVS, an Official Veterinarian (OV) and fellow director of Mr Evans’ practice in Cardigan, the cattle on his farm requiring intradermal comparative tuberculin tests; that he tested certain of the cattle himself despite not being the OV for those tests and having a conflict of interest; and that he provided inaccurate and incomplete information to his practice for the completion of a report on the testing to be sent to the Animal Health and Veterinary Laboratories Agency (AHVLA). This misconduct was then repeated the following year between 19 June and 1 August 2014.
The second head of charge against Mr Evans related to breaches of the Cattle Identification (Wales) Regulations 2007 between 4 July 2005 and 20 June 2014, namely the fact that he failed to register the birth of five calves and the death of nine cows. These were accepted as being specimen charges reflecting a much larger total number of breaches over the whole nine year period.
Mr Evans’ misconduct first came to light when a late return was sent to the AHVLA in August 2014 regarding the TB testing of 51 live animals on his farm in June 2014. When the report was scrutinised the AHVLA noticed that 26 animals shown on the return as dead were still registered, while 20 animals that were tested were not registered. When the AHVLA investigated, Mr Evans immediately admitted that he had misled Mr Lewis on two occasions and carried out his own testing despite not being the OV.
The Committee heard that he did this because he did not want it to be found out that he had unregistered cattle on his farm. Regarding the unregistered cattle, the Committee heard that this stemmed from a mistake made by Mr Evans in 2005 or 2006 whereby he mislaid a batch of around nine bovine passport application forms sent to him to register the birth of calves on his farm, a legal requirement for the purposes of animal health, disease control and safeguarding the food chain.
As a result of poor IT skills and being profoundly deaf, Mr Evans felt unable to seek support online or by telephone, was too embarrassed to tell others and, furthermore, felt that it was impossible to correct his mistake without being in breach of the law. So, for a period of nine or 10 years, he failed to register the birth of calves on his farm. His failure to register the deaths of cattle, was also caused by administrative failings. His breaches of the cattle registration regulations were subject to criminal proceedings and on 14 October 2015 he plead guilty at Ceredigion and Pembrokeshire Magistrates Court to 14 offences for which he was given a conditional discharge for 18 months and ordered to pay costs of £1,000.
The Committee considered that a suspension from the Register would be in line with the seriousness of the charges against Mr Evans. Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee agrees that the lengthy period over which these offences took place, his betrayal of his colleague, and the undermining of the reputation of the profession and of the system of disease control, taken together with his dishonesty, make it impossible to impose a lesser sanction than suspension.
"The Committee finds that the respondent, who is a man of good character, has fully accepted his guilt, and has real insight into the seriousness of his conduct. He cooperated fully with the investigations and with the County Council who prosecuted him in the Magistrates [Court], and with the College. He made an open and frank admission about his misconduct from the outset.
"The course of conduct on which he embarked and which has led to these charges was the result of a simple mistake at a time of considerable stress to him. He was not guilty of deliberate misconduct at the outset but… what started as an innocent mistake took on a life of its own and led him to deliberate and dishonest misconduct because he did not know how to get himself out of the predicament he was in."
Professor Barr also said that there was no financial gain in Mr Evans’ actions and that animal welfare had not been compromised as the cattle were well cared for and in good health and that Mr Evans’ actions in carrying out the tuberculin tests on the unregistered cattle himself demonstrated that he was concerned about identifying any disease in his herd.
He added: “In all the circumstances the Committee has decided a proportionate sanction is that the respondent’s registration should be suspended for a period of six months.”
The Committee’s full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
Dickson Company has launched the Dickson Alarm Thermometer, a tool to ensure that vaccine and drug storage temperatures in both refrigerators and freezers fully comply with regulatory requirements.
Featuring tamper-resistant audible and visual alarms, the Dickson Alarm Thermometer costs US$59 for a two probe model (MM125) that can monitor both refrigerators and freezers simultaneously and US$49 for a single probe model (MM120).
Both the MM125 and MM120 models are continuous, calibrated and certified thermometers that are able to monitor temperatures in the -58 to +158°F (-50 to +70°C. For more technical details on Dickson Alarm Thermometers see (www.dicksondata.com/product/model_MM120.php).
Product inquiries can be directed to Dickson customer service at dicksoncsr@dicksondata.com, or calling 800-757-3747 or +1-630-543-3747 outside the US, FAX +630-543-0498 or by writing Dickson, 930 South Westwood Avenue, Addison, IL 60101, USA.
Sioned Timothy, Ruminant Technical Manager at Boehringer said: "The financial and production impact of liver fluke should not be underestimated. Recent abattoir research in Ireland, published this year, has shown that a fattening steer with fluke infection will put on 36kg less live weight gain over its lifetime versus a healthy steer, costing the producer around £63, per animal.
"Additionally, analysis of data from cattle at a Scottish abattoir showed that animals with 1 to 10 liver fluke present in their liver took an average 31 days longer to reach slaughter weight, while animals with more than 10 liver fluke present took an additional 77 days longer to reach slaughter weight versus animals without any liver fluke infection2.
"Liver fluke infections can also lead to hormonal and metabolic imbalances, affecting reproduction in female animals and extending breeding targets3. Affected animals may also be more susceptible to secondary bacterial infections, such as Salmonella and Clostridial infections3."
Boehringer says that with cattle being brought in for winter housing, now is an ideal opportunity to remove productivity-limiting parasites that were acquired during the grazing season. The main targets for parasite control at this time of year are gutworms, lungworm and liver fluke, however the specific risk will vary from farm to farm.
The company adds that the choice of treatment for liver fluke at housing is complicated by emerging resistance to triclabendazole. This is the only flukicide that treats the early immature stage of liver fluke, responsible for acute disease in sheep but not of clinical relevance in cattle.
Sioned said: "Prescribing an alternative flukicide for cattle at housing will reduce selection for resistance and, by targeting the later stages of the parasite, control the impact of liver fluke on productivity.
"Flukicides containing clorsulon (contained in Ivomec Super) will remove the adult stages of fluke in cattle, while those containing closantel, or nitroxynil (the active ingredient of Trodax), are effective against both late immature and adult stages.
"To ensure that cattle have no residual fluke burden, they may need to be re-treated at an appropriate interval after the initial housing dose. Diagnostic testing can be used to determine whether a second treatment is necessary. This approach will ensure that cattle are turned back out onto pasture fluke free."
References
The National Office of Animal Health has issued a statement criticising the All Party Parliamentary Group on Antibiotics report: "Non-human uses of antibiotics: time to restrict their use?”, saying it fails to recognise the steps that have already been taken by vets and farmers to prevent disease and minimise antibiotic use on farms where possible.
NOAH chief executive Dawn Howard said: "NOAH fully supports the need for responsible prescribing, by both the veterinary and medical professions.
"On the veterinary side, NOAH has been very actively involved with responsible use initiatives, such as the RUMA Alliance, which publishes guidelines supporting responsible use and has produced an action plan on livestock antibiotic resistance to implement Government strategy.“
NOAH highlights two particular aspects of the report. Firstly that it is critical of the treatment of groups of animals through medicated feed and water.
Dawn said: "There are many animal-friendly reasons why medicines can be prescribed in this way by a veterinary surgeon.
"For groups of animals, fish or birds there is less stress than injection or individual oral dosing. Where treatment is needed, the vet supplies a prescription for treatment through medicated feed or through the water, depending on the product being used. The whole process is highly regulated through European and national legislation."
The report also suggests certain classes of antibiotics should be reserved for humans. NOAH says it believes that veterinary surgeons need to retain the full range of currently licensed antibiotics in order to be able to treat the range of conditions that affect animals, and if they are restricted, animal welfare will undoubtedly suffer.
NOAH adds that removal of some classes from the veterinary sector would place undue selective pressure on the remaining classes which could increase resistance to those classes – having the opposite effect to what the committee probably intends.
Dawn said: “NOAH is disappointed not to have been consulted in advance of the publication of the report. We believe that responsible use of veterinary antibiotics is the best way to help preserve these precious medicines for us all, without compromising the health and welfare of our animals.”
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
Fort Dodge, which supplies Bluetongue vaccine in continental Europe, has licensed its cattle vaccine in the UK and is now launching the product onto the UK market.
The company has already won and met tenders from several European governments, including France, Spain, Italy, Portugal Germany, Switzerland, Belgium and the Czech Republic for its Zulvac 8® Bovis vaccine and says it is the only international company to have produced vaccines for the most commonly occurring serotypes of the disease including 8, 4 and 1.
Approved by the VMD with a Provisional Marketing Authorisation, Zulvac 8 is available in 50 dose and 10 dose packs. The key claims are active immunisation against Bluetongue serotype 8 of cattle from 2.5 months old and a significant reduction of viraemia.
The vaccine is administered in 2 x 2 ml doses at three week intervals given by intra muscular injection and the product is supported by a fixed 2ml multidose applicator with Sterimatic needle protector and cleaning system to ensure accurate dosing and hygienic conditions.
John Hanley, Managing Director of Fort Dodge UK, said: "We were first to market with our Zulvac 8 product in three European countries and have received an Award for Agricultural Merit from the Spanish Government for our work in Bluetongue control. Following the licensing of Zulvac 8 Bovis in the UK we now have the opportunity to launch the product onto the UK market.
"In terms of pricing, Zulvac 8 is competitive per dose against other products in the market and it is supported by the experience gained in Europe with millions of animals already vaccinated. We're delighted that the VMD have authorised the vaccine and believe its availability can play a key role in protecting the UK's cattle from this dreadful disease."
The product is authorised for use by cattle farmers in the protection zone only, and will require veterinary prescription. Farmers can administer the vaccine to their cattle and the 2ml intra-muscular injection will be an advantage in aiding administration especially when used with Zulvac Bovis applicator with sterimatic needle protector and cleaning system.
The first batches will be available from veterinary wholesalers from week commencing 22nd September 2008.
The broached bottle must be kept refrigerated between 20C and 80C until the next use.
Virbac says that whilst this may not seem a huge change, it significantly increases the cost-effectiveness and convenience to farmers.
The SPC changes mean that
Bovigen Scour is available in 5 and 30 dose bottles.
Developed in conjunction with Fiona Lovatt BVSc PhD FHEA DSHP DipECSRHM FRCVS, past president of the Sheep Veterinary Society and RCVS-recognised specialist in sheep health and production, NoBACZ Navel disinfects and dries the navel in a couple of hours and seals with a colourful, natural resin that forms a long-lasting waterproof barrier to protect against bacterial ingress from the environment.
It can also be used on the area around ear tags in lambs and calves.
Nobacz Navel can be applied by dipping or spraying and contains a bitter agent to deter ewe or cow interference.
Fiona said: “Attention to detail is an essential component in the care of neonatal lambs.
"To reduce the risks of joint ill, shepherds need to do whatever they can to protect lambs from bacteria infecting either the navel or the ears at the point of tagging.
"This product has been carefully designed to both desiccate the area and to form a barrier to protect these vulnerable sites.
"I’ve seen it used successfully in a number of flocks now – both in late lambers from last year and early lambers from this.”
https://nobacz.com
DairyCo has announced the launch of a new programme designed to tackle the challenge of lameness on dairy farms.
The Healthy Feet Programme has been developed to provide a structured approach to assist vets and foot trimmers to work more closely with their farmer clients, to reduce the incidence of lameness on a permanent basis.
DairyCo product manager, Kate Cross said: "We've developed the programme to build on the DairyCo Mobility Score by introducing a programme that dairy farmers can undertake working with their vet who is a trained 'mobility mentor', to identify problems, risk factors and suitable intervention strategies on the farm. An action plan is then agreed to prioritise management practices that have a permanent impact on incidence of lameness."
The programme draws on the findings from the Bristol Healthy Feet Project, the New Zealand Healthy Hooves programme, First Steps and Claw Signals. As well as the valuable experience gained from the DairyCo mastitis plan. It has been designed to combine the best features of all these programmes and aims to build on the successful DairyCo Mobility Score.
Vets are invited to enrol for a two day CPD course, which will enable them to introduce the Healthy Feet Programme to their farmer clients and provide on-going support, assisted by a range of resources provided by DairyCo.
The first course is scheduled for June 2011
For further details please contact Kate Cross on 02476 478686 or email healthyfeet@dairyco.ahdb.org.uk
Horiba Medical has announced it is the official exclusive UK distributor of the fully automated Vet abc Plus+ veterinary haematology analyser from scil animal care company GmbH, Germany.
According to the company, the compact Vet abc Plus+ provides a complete blood count (CBC), including 4-part white blood cell (WBC) differential, from only 10 µl of EDTA whole blood, in only 60 seconds.
The Vet abc Plus+ provides pre-installed settings to analyse samples from dogs, cats, horses, rabbits, mice, rats, cattle, pigs and sheep. For dogs, cats and horses, the Vet abc Plus+ provides a 4-part WBC differential blood count, including a differentiation of the leucocytes to identify lymphocytes, monocytes, granulocytes and eosinophils. Results are available in 60 seconds on screen or can be automatically printed out and transferred to the practice information system or clinical notes. For ease-of-use, the Vet abc Plus+ also incorporates a self-contained reagent and waste system which provides a clean operation whilst being easy to replenish.
Borne from an existing manufacturing partnership, scil and HORIBA Medical already have over 6000 veterinary haematology analysers placed globally. Horiba says the new UK distribution agreement enables UK veterinary professionals to not only procure the Vet abc Plus+ analyser, but also receive expert service and support directly from the manufacturer HORIBA Medical and its team of UK specialists.
For more information, visit: www.horiba.com/uk/medical
Intervet/Schering-Plough has announced that the license for Leptavoid-H has been improved allowing concurrent use with Bovilis BVD.
Intervet/Schering Plough says that given both vaccines are typically administered in the busy pre-turnout period, this will ease on-farm workload and should help to ensure that all primary courses or boosters take place sufficiently in advance of the period of risk.
Each vaccine is to be given by separate routes and sites, to animals of 8 months or older. The concurrent use in cattle may result in fewer animal interventions, less stress and better welfare.
The studies, undertaken by Intervet/Schering Plough's R&D division in the UK, focussed on both the safety and efficacy aspects of the concurrent administration of Leptavoid-H with Bovilis BVD. The company says no systemic adverse events occurred, there was no effect on the outcome of pregnancy or milk yields and the efficacy in cattle was not compromised.
Leptavoid-H is licensed to reduce the shedding of Leptospira interrogans serovar hardjo in urine. Leptavoid-H is the only Leptospirosis vaccine licensed to improve herd fertility when Leptospira hardjo is the cause of herd infertility, and the only vaccine proven to protect stock against both strains in the UK.
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
The four-day course, which is organised by Embryonics, will take place in Cheshire and runs from Monday 24 February to Thursday 27 February.
The course will cover the five-step Dutch method of foot trimming, which Ceva says is the most successful tried and tested method of trimming for reducing the incidence of lameness in the herd.
Course tutors include John Dawson MRCVS BVMS CertCHP Dip Cattle footcare and a Ceva representative will also present information on how the management of pain and inflammation fits into a comprehensive lameness treatment programme. The practical course is a recognised route to becoming a NACFT (National Association of Cattle Foot Trimmers) licensed foot trimmer.
Peter Keyte, ruminant business unit manager at Ceva, comments: "We would like to encourage livestock vets, farmers and professional foot trimmers to work more closely together, as a team, to help prevent lameness in cattle. We are therefore delighted to be supporting the industry by sponsoring this course, which will help raise welfare standards across the industry."
For further information on the Professional Foot Trimming course, please visit www.embryonicsltd.co.uk.
Novartis Animal Health has announced that Crovect 1.25% Pour-On solution for sheep, a broad spectrum ectoparasiticide, is now licenced for the treatment of ticks, with a persistent efficacy of ten weeks and the majority killed within three hours.
Crovect also works in the treatment and control of headflies, the treatment of biting lice, and the prevention and treatment of blowfly strike in sheep.
Crovect has a meat withhold period of eight days. Novartis says this makes Crovect the long-lasting tick treatment with the shortest meat withhold period available, which is of use to farmers taking lambs to market at this time of year.
Helen Langham, Brand Manager at Novartis Animal Health said: "Farmers now have another option available for effective and long lasting tick treatment for their flocks, and one that can be flexibly used in lambs to be marketed. This should greatly reduce the worry of tick infestation along with the associated welfare and economic problems, and we are pleased to bring this solution to the market".
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
The company says the workshop will provide vets with an opportunity to extend their knowledge of Q Fever, a zoonotic disease that not only affects reproductive performance and productivity in cattle but also presents a health threat to farmers, farming families and related professions such as vets, veterinary technicians and abattoir workers.
The workshop will be presented by Raphaël Guatteo (pictured right), Professor in Bovine Medicine and Health Management at the Veterinary College of Nantes (Oniris) in France.
Raphaël will share his wealth of knowledge on Q Fever including his extensive research into the disease.
He'll answer any questions that delegates may have about Q Fever and will discuss case studies, diagnostic challenges and the importance of quick diagnosis, treatment options and prevention through vaccination.
The Q Fever workshop will take place between 4.00pm and 5.30pm on Thursday 20 October in the Shorthorn Room at the Hilton Metropole in Birmingham.
The workshop is free of charge, but spaces are limited.
There had already been a gap in supply of the vaccine between June and August due to a batch being out of specification.
The company says it submitted an Out of Specification request to release the vaccine but was unsuccessful.
The next delivery of vaccine was expected at the end of August, however this has unfortunately been delayed until October, and there is no certainty of this delivery.
Ceva says it deeply regrets the inconvenience caused to sheep farmers this year.
Roy Geary, Vice President for Northern Europe (including the UK) at Ceva Animal Health, said: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.
"There have been unforeseen manufacturing issues at our production facilities, which have temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE.
"As a responsible provider, we are actively addressing these issues to minimise the impact on customers.”
“We are recommending that vets and farmers follow the advice published on 24th July 2024 from the Sheep Vet Society and Sheep Antibiotic Guardian Group (SAGG).”
https://sheepvetsoc.org.uk/news/sheep-veterinary-society-svs-and-sheep-antibiotic-guardian-group-sagg-advice-for-when-an-enzootic-abortion-eae-vaccine-is-unavailable.
The new 10ml (10-dose) and 100ml (100-dose) packs of Ingelvac PRRS EU are available now, and will complement the existing 50ml (50-dose) packs.
Callum Blair MRCVS, Swine Brand Manager at Boehringer Ingelheim, said: "Nobody likes to end up with part used bottles of any vaccine that then have to be discarded. The addition of Ingelvac PRRS EU 10-dose and 100-dose packs will provide choice for different sized units and help reduce wasted doses."
For more information, visit www.prrs.com.
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
Grahame Gardner Ltd has announced the launch of a classically styled tunic, the M559, now stocked in bottle green for the first time.
The company says that although there have been numerous ladies tunics available in bottle green, this is the first time Grahame Gardner has stocked a male tunic in the characteristic veterinary colour.
The contemporary design of the M559 incorporates side fastening with the option of contrasting epaulettes, alongside practical pockets and side slits. According to the company, it's a tunic that looks great and performs exceptionally well in the veterinary practice. Stocked in sizes from 34" to 50" (chest), the M559 is one of several new styles introduced within Grahame Gardner's latest 124 page brochure.
To explore Grahame Gardner's collection please take a look at http://www.grahamegardner.co.uk/, or call 0116 255 6326 to order a copy of the new brochure.
BCF Technology has launched the portable 9020HF Orange x-ray generator from Eco Ray.
BCF says the 9020HF is ideal for equine and large animal applications because it is is just marginally heavier than the 8016HF generator, but more powerful, allowing it to achieve excellent images of regions such as the stifle and spine.
The new BCF Clinical Development Manager and in-house vet Kimberly Palgrave said: "This new generator really fills the gap in the range and is an ideal balance between weight and power. It is also bright orange so impossible to miss when tidying the kit away in the yard."
BCF is also the sole official distributor in the UK and Ireland for Eco Ray generators.
To see the full range of X-ray generators and other X-ray and ultrasound equipment available from BCF visit http://www.bcftechnology.com/ or call +44 (0)1506 460023.
Ceva Animal Health has launched ReprodAction, a new series of webinars to help address the problems commonly faced in bovine reproduction management.
James Husband, RCVS Specialist in Cattle Health and Reproduction, kicked off the series at the beginning of November with a live webinar for XLVet members: Assessing Fertility Records.
His presentation, which is now accessible to all large animal vets at http//onsync.digitalsamba.comn/go/ceva/ReprodAction, explores the common pitfalls and provides practical pointers for good fertility management. He discusses the limiting factors of oestrus detection, use of the calving interval as an assessor of individual fertility performance, implications of the varied definitions of conception rates, use of milk recording organisation data and the usefulness of the 21 day in calf rate.
Each webinar in the series is presented by a leading expert and has a facility for live chat and question and answer sessions.
For further information and details of when the next ReprodAction webinar will be taking place, contact Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.